cyclosporine has been researched along with Anti-Phospholipid Antibody Syndrome in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Długosz, G; Masajtis-Zagajewska, A; Nowicki, M | 1 |
| Choi, YJ; Yoo, WH | 1 |
| Ben-Chetrit, E; Tayer-Shifman, OE | 1 |
| Dönmez, O; Durmaz, O | 1 |
| Bravo, JC; Cañas, CA; Castaño, DE; Durán, CE; Tobón, GJ | 1 |
| Komiya, T; Muso, E | 1 |
| Kiss, CG; Kiss, E; Poór, G | 1 |
| Besbas, N; Bilginer, Y; Cetin, M; Gokce, M; Gumruk, F; Ozaltin, F; Ozen, S | 1 |
| Chiang, BL; Lee, JH; Lin, CI; Lin, YT; Wang, LC; Yang, YH; Yu, HH | 1 |
| Constantin, T; Dankó, K; Ponyi, A | 1 |
| Al-Flaiw, A; Al-Ghamdi, G; Ghalib, M; Hala, K; Hejaili, F; Jumani, A; Khader, AA; Qureshi, J; Raza, H; Tahir, S | 1 |
| Shoenfeld, Y | 1 |
| Agostini, C; Biasiolo, A; De Silvestro, G; Livi, U; Marson, P; Pengo, V | 1 |
| Amend, WJ; Criswell, LA; Millward, CL; Olson, JL; Stone, JH | 1 |
| Balacco Gabrieli, C; Giorgi, D | 1 |
| Breitbart, A; Fiehn, C; Germann, G | 1 |
4 review(s) available for cyclosporine and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
[Ischemic tubulointerstitial injury].
Topics: Acute Disease; Antiphospholipid Syndrome; Arteriosclerosis; Calcineurin Inhibitors; Chronic Disease; Contrast Media; Cyclosporine; Humans; Infarction; Ischemia; Kidney Cortex Necrosis; Kidney Diseases; Renal Artery | 2011 |
[Systemic autoimmune disorders and pregnancy].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha | 2011 |
Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adjuvants, Immunologic; Androgens; Animals; Antibodies, Anti-Idiotypic; Antiphospholipid Syndrome; Aspirin; Bone Marrow Transplantation; Bromocriptine; Cyclosporine; Disease Models, Animal; Estrogens; Ethylenes; Heparin; Hydroxyquinolines; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Transfusion; Mice; T-Lymphocytes, Regulatory | 1994 |
Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis.
Topics: Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Azathioprine; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Optic Nerve Diseases; Prednisolone; Visual Acuity | 1999 |
12 other study(ies) available for cyclosporine and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
[Efficacy of rituximab in minimal change disease, an atypical renal manifestation of antiphospholipid syndrome].
Topics: Adult; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Anticoagulants; Antiphospholipid Syndrome; Cyclophosphamide; Cyclosporine; Humans; Infant; Kidney; Kidney Diseases; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Rituximab; Young Adult | 2022 |
Pyoderma gangrenosum masquerading as an ulcer related to antiphospholipid antibodies in a patient with systemic lupus erythematosus.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Cyclosporine; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Pyoderma Gangrenosum; Skin; Skin Transplantation; Ulcer | 2018 |
Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome - Successful use of PET- CT and Anakinra in its diagnosis and treatment.
Topics: Adult; Antiphospholipid Syndrome; Antirheumatic Agents; Cyclosporine; Female; Humans; Interleukin 1 Receptor Antagonist Protein; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Calcinosis cutis universalis with pediatric systemic lupus erythematosus.
Topics: Administration, Oral; Antiphospholipid Syndrome; Aspirin; Calcinosis; Child; Cyclosporine; Dermatologic Agents; Diltiazem; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Skin Ulcer; Treatment Outcome | 2010 |
Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation.
Topics: Adult; Antiphospholipid Syndrome; Cohort Studies; Cyclosporine; Dosage Forms; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Leg Ulcer; Middle Aged; Pyoderma Gangrenosum; Time Factors; Treatment Outcome; Warfarin | 2010 |
Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children.
Topics: Adolescent; Anemia, Hemolytic; Antibodies; Anticoagulants; Antiphospholipid Syndrome; Cardiolipins; Child; Child, Preschool; Cyclosporine; Female; Heparin, Low-Molecular-Weight; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Leukopenia; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Phospholipids; Plasma Exchange; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Steroids; Thrombotic Microangiopathies; Venous Thrombosis | 2012 |
Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
Topics: Adolescent; Antiphospholipid Syndrome; Arthritis, Juvenile; Autoimmune Diseases; Child; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Methylprednisolone; Retrospective Studies; Treatment Outcome | 2012 |
Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap.
Topics: Adult; Antibodies, Antinuclear; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Hand; Humans; Ligases; Lung; Lung Diseases, Interstitial; Magnetic Resonance Imaging; Polymyositis; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation.
Topics: Acute Disease; Adult; Antiphospholipid Syndrome; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lupus Erythematosus, Systemic; Male; Microcirculation; Middle Aged; Postoperative Period; Retrospective Studies; Tacrolimus; Thrombosis | 2004 |
Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Azathioprine; Cardiomyopathy, Dilated; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Myocardial Infarction; Plasmapheresis; Preoperative Care; Treatment Failure | 1996 |
Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Topics: Adult; Analysis of Variance; Antibodies; Antibodies, Antinuclear; Antiphospholipid Syndrome; Biopsy; Cadaver; Cell Count; Cell Size; Cyclosporine; Female; Follow-Up Studies; Glomerular Mesangium; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Recurrence; Renal Dialysis; Time Factors; Transplantation Conditioning | 1998 |
Autologous skin transplantation for widespread cutaneous necrosis in secondary antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Cyclosporine; Dermatologic Surgical Procedures; Female; Humans; Immunosuppressive Agents; Necrosis; Prednisone; Reoperation; Skin; Skin Diseases; Skin Transplantation; Treatment Outcome | 2001 |